Trial intelligence / Profile preview

Glycopyrronium wipes in axillary hyperhidrosis

NCT02530281Phase 3Completed

Sponsor
Journey Medical Corporation
Start
Jul 2015
Primary completion
Mar 2016
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of glycopyrronium in hyperhidrosis, sponsored by Journey Medical Corporation. Started Jul 2015; status: completed.

02

Drugs

glycopyrronium
03

Conditions

hyperhidrosis

Beyond the preview

Go deeper on NCT02530281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02530281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call